Red Tortoise LLC’s Cullinan Oncology CGEM Stock Holding History

Red Tortoise LLC’s Portfolio CGEM Stock Details CGEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-140	Closed	-$1.51K	–	561
2023 Q2	$1.51K	Buy	+140	New	+$1.49K	﹤0.01%	505

Other funds holding CGEM

MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIG

American International Group New York $609M AUM 23.67% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Red Tortoise LLC's CGEM Position: Q3 2023 in Review

Red Tortoise LLC sold out of Cullinan Oncology (CGEM) in Q3 2023, closing a stake of 140 shares — an estimated $1.51K sold.

Red Tortoise LLC first reported a position in CGEM in Q2 2023 and held it in 1 quarter. The position peaked at $1.51K in Q2 2023. 106 funds tracked by Wall St. Rank hold CGEM as of Q3 2023.

Red Tortoise LLC reported no remaining Cullinan Oncology position as of Q3 2023 after selling out during the quarter.
Red Tortoise LLC sold 140 Cullinan Oncology shares in Q3 2023, an estimated $1.51K.
Red Tortoise LLC first reported a position in Cullinan Oncology in Q2 2023 and held it in 1 quarter.
Red Tortoise LLC's Cullinan Oncology position peaked at $1.51K in Q2 2023.
106 funds tracked by Wall St. Rank held Cullinan Oncology as of Q3 2023.

Based on Red Tortoise LLC's 13F filing for Q3 2023, filed 2 Nov 2023.